| NCT06976229 | Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | | - Age 18 - 65 yrs
- Level C4-L2
AIS A, B, C- 14 days - 60 days
| Recruiting | 12 | PHASE1 | Biological/cell based | General health | - Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS)
- Feasibility
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Spinal Cord Independence Measure (SCIM)
| 1 year | 02 July 2025 | 16 May 2025 | 1 | |
| NCT06723561 | Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury | Medical College of Wisconsin | | - Age ≥ 18 yrs
- Level C1-T12
AIS - ≥ 6 months
- experience central neuropathic pain, based on evaluation by a Physical medicine and rehabilitation physician
| Recruiting | 10 | PHASE2 | Drug | Mental health and psychosocial factors | - Neuropathoc Pain Symptom Inventory (NPSI)
- Quality of Life Index (QLI) - SCI Version
| 12 weeks | 01 February 2025 | 09 December 2024 | 1 | |
| NCT06838637 | Transcutaneous Spinal Cord Stimulation Home Study | University of British Columbia | | - Age 19 - 70 yrs
- Level C1-T6
AIS A, B- ≥ 1 years
- NOT have an intrathecal baclofen pump
- NOT have any implanted metal (other than dental implants) in the skull or presence of pacemakers, stimulators, or medication pumps in the trunk
- NOT have undergone electrode implantation surgery
| Recruiting | 6 | NA | Technology | General health | - Adverse Events (AEs)
- Blood Pressure and Heart Rate Regulation
- Surface Electromyography (sEMG)
| 10 weeks | 15 February 2024 | 20 February 2025 | 1 | |
| NCT06700304 | CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices | Neuralink Corp | | - Age ≥ 19 yrs
- Level C1-T1
AIS B- ≥ 12 months
- NOT have an active implanted devices
- Not require an MRI during the study
| Recruiting | 6 | NA | Technology | General health | - Adverse Events (AEs)
- Generalized Anxiety Disorder (GAD-7)
- Patient Health Questionnaire-9 (PHQ-9)
| 6 years | 20 November 2024 | 21 November 2024 | 1 | |
| NCT07167680 | Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters | University of Illinois at Urbana-Champaign | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 120 | NA | Psychosocial/other | General health | - System Usability Scale (SUS)
- Wheelchair Skills Test (WST, 4.1)
| 14 weeks | 01 September 2025 | 11 September 2025 | 1 | |
| NCT06543277 | Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury | The University of Texas Health Science Center, Houston | | - Age ≥ 18 yrs
- Level C1-C8
AIS B, C, D- 12 months - 10 years
- NOT have intracranial metal implants or pacemakers
| Recruiting | 12 | NA | Technology | General health | - Adverse Events (AEs)
- Blood Pressure and Heart Rate Regulation
- Capabilities of Upper Extremity Instrument (CUE- Q and CUE-T)
- Feasibility
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Patient Health Questionnaire-9 (PHQ-9)
- Spinal Cord Independence Measure (SCIM)
- Toronto Rehabilitation Institute Hand Function Test
| 20 weeks | 15 August 2025 | 07 August 2024 | 2 | |
